Mandukaparni (Centella asiatica) vs Brahmi: Resolving the Identity Confusion in Ayurveda

Few naming problems in Ayurvedic pharmacognosy are as persistent as the Brahmi–Mandukaparni confusion. In prescriptions, product labels, regional practice and household use, the word “Brahmi” may point to Bacopa monnieri, Centella asiatica, or a mixture of both. This matters because the two plants are botanically distinct, carry different pharmacognostic markers, and are used with different practical expectations in Ayurveda and in contemporary herbal practice.

The cleanest way to resolve the confusion is to keep the traditional name and the botanical name together. In current pharmacopoeial usage, Brahmi is Bacopa monnieri and Mandukaparni is Centella asiatica. Both are valuable medhya-type herbs, but they should not be treated as interchangeable without knowing exactly which plant is being used.

The Two Plants in Question

The following comparison gives the practical identification points most relevant for practitioners, students and consumers. It combines pharmacopoeial identity, plant morphology and modern marker-compound distinctions.

Feature Brahmi: Bacopa monnieri Mandukaparni: Centella asiatica
Pharmacopoeial identity Brahmi whole plant is Bacopa monnieri (Linn.) Wettst. Mandukaparni whole plant is Centella asiatica (Linn.) Urban
Modern botanical family Plantaginaceae; older Ayurvedic pharmacopoeial listings may place it under Scrophulariaceae Apiaceae, also called Umbelliferae
Growth habit Small, succulent, prostrate or creeping herb of wet and damp places Stoloniferous creeping herb, rooting at nodes
Leaf character Simple, opposite, sessile, obovate-oblong leaves, slightly bitter in taste Orbicular-reniform leaves with crenate margin and cordate base; the leaf form explains the “manduka-parni” name
Common marker compounds Triterpenoid saponins, especially bacosides Pentacyclic triterpenoids such as asiaticoside, madecassoside, asiatic acid and madecassic acid
API rasa Madhura, tikta, kashaya Tikta
API guna Laghu, sara Laghu, sara
API virya Shita Shita
API vipaka Madhura Madhura
API karma highlights Medhya, rasayana, kapha-vatahara, ayushya, matiprada Medhya, rasayana, deepana, kapha-pittahara
API dose 1–3 g powder 5–10 g dried drug

Where the Confusion Comes From

The confusion is not simply a modern marketing error. The Ayurvedic Pharmacopoeia of India itself shows why regional language can mislead. The Brahmi monograph for Bacopa monnieri includes vernacular names such as “Manduka Parni” in Hindi and “Mandukaparni” in Kannada, while the Mandukaparni monograph for Centella asiatica includes “Brahmi” in Hindi, Punjabi and Urdu, and “Brahmi soppu” in Kannada. In other words, the same vernacular names have crossed over between the two plants.

This is why the botanical name is not a minor technical detail. A label that says only “Brahmi” may still be ambiguous unless it states Bacopa monnieri, Centella asiatica, or both with quantities.

Classical Context

In the Rasayana chapter of the Charaka Samhita, Mandukaparni appears specifically in the medhya rasayana passage: Mandukaparni juice, Yashtimadhu powder with milk, Guduchi juice, and Shankhapushpi paste are named as rasayana preparations that support life, strength, agni, complexion, voice and medha. Brahmi also appears in Charaka in a separate rasayana context, including Aindra Rasayana. This supports the need to read the classical name in context rather than forcing every “Brahmi” and “Mandukaparni” reference into one plant.

Modern pharmacopoeial standardization resolves the practical dispensing question by assigning Brahmi to Bacopa monnieri and Mandukaparni to Centella asiatica. That is the safest convention for prescriptions, product labels, research reports and consumer guidance.

Pharmacognostic Differences

When the fresh plant is available, the difference is visible. Bacopa monnieri has small, opposite, fleshy leaves and a wetland habit. Centella asiatica has longer petioles and kidney-shaped to nearly circular leaves, arising from a creeping stoloniferous plant. Microscopic and phytochemical profiling also separates them clearly.

Identification point Bacopa monnieri Centella asiatica
Habit Juicy, succulent, glabrous herb rooting at nodes Small creeping herb with slender stem, rooting at nodes
Leaves Simple, opposite, sessile, fleshy Simple leaves with elongated petiole and reniform outline
Microscopy Plenty of air cavities, matching its wet habitat Dorsiventral leaf histology with differentiated midrib and striated cuticle
Phytochemical distinction Alkaloids, saponins, glycosides and tannins reported in screening Alkaloids, saponins, glycosides and tannins reported, with flavonoids also noted in comparative screening

Why the Distinction Matters Clinically

Both herbs are used in mind-and-nervous-system contexts, but the practical emphasis differs. Bacopa monnieri is the plant most often examined in standardized oral extracts for cognitive performance, attention and memory-related outcomes. Centella asiatica has a strong identity in skin, connective tissue, wound support and venous microcirculation contexts, while also being used traditionally as a medhya herb.

Practical goal Preferred botanical identity Why botanical identity matters
Memory, learning and attention support in adults Bacopa monnieri The best-known human cognitive trials used standardized Bacopa extracts, commonly over repeated daily use for weeks
Calming medhya support where sleepiness is not a concern Bacopa monnieri, selected carefully Bacopa is commonly described as a calming cognitive herb and may be mildly sedating in some users
Skin recovery, scars and topical wound-support formulations Centella asiatica Centella triterpenoids are widely associated with connective-tissue and skin-repair applications
Venous insufficiency and venous microcirculation support Centella asiatica triterpenic fraction under professional guidance Purified Centella triterpenic fractions have been used in clinical work on venous hypertension and chronic venous insufficiency
Classical medhya rasayana context of Mandukaparni swarasa Centella asiatica The pharmacopoeial Mandukaparni identity is Centella, and Charaka specifically names Mandukaparni juice in the medhya rasayana passage
Ayurvedic Brahmi formulations such as Brahmi Ghrita or Saraswatarishta Usually Bacopa monnieri under pharmacopoeial convention The API Brahmi monograph lists Brahmi Ghrita and Saraswatarishta among important formulations for Brahmi

Bacopa monnieri: Brahmi in Pharmacopoeial Usage

In the Ayurvedic Pharmacopoeia of India, Brahmi is defined as the dried whole plant of Bacopa monnieri. Its official Ayurvedic properties are madhura-tikta-kashaya rasa, laghu-sara guna, shita virya and madhura vipaka. The monograph lists medhya, rasayana, kaphahara, vatahara, ayushya and matiprada among its actions, and gives 1–3 g powder as the dose.

Contemporary Bacopa preparations usually specify bacoside content. Standardized extracts in adult trials commonly fall around 300–450 mg per day, while traditional crude-herb dosing is higher. Because Bacopa may cause gastrointestinal discomfort and mild sedation in some users, it is commonly taken with food and selected cautiously in people already using sedatives, anticholinergic drugs, thyroid medication or multiple prescription medicines.

Centella asiatica: Mandukaparni in Pharmacopoeial Usage

In the Ayurvedic Pharmacopoeia of India, Mandukaparni is defined as the dried whole plant of Centella asiatica. Its official Ayurvedic properties are tikta rasa, laghu-sara guna, shita virya and madhura vipaka. The API dose is 5–10 g of the dried drug.

Centella contains triterpenoid compounds such as asiaticoside, madecassoside, asiatic acid and madecassic acid. In practical use it is often associated with skin, wound, connective-tissue and venous applications, while in Ayurveda it also retains a medhya identity through Mandukaparni. It is also eaten as a food in some regions, but concentrated extracts should be treated differently from culinary use.

Safety Profiles: Key Differences

Correct identification matters because the two plants do not carry identical cautions. The following table summarizes practical safety distinctions without replacing individualized medical advice.

Safety point Bacopa monnieri Centella asiatica
Common adverse effects Gastrointestinal effects such as increased stool frequency, nausea and abdominal cramps are the main practical concern Usually mild, transient effects such as headache, dizziness, bloating, diarrhea or nausea may occur with oral extracts
Sedation May be mildly sedating; use caution with sedatives or when alertness is required Drowsiness can occur in some users, especially with higher oral intake
Thyroid caution Animal data and clinical cautions suggest extra care in thyroid disease or with thyroid hormone medication No comparable thyroid-specific caution is central to the Centella monograph, but medical review is still appropriate
Drug-interaction caution Use caution with anticholinergic or cholinergic drugs and medicines metabolized through CYP pathways Use caution with liver disease, sedatives and complex medication regimens
Liver caution No common hepatotoxicity signal is central to standard Bacopa use at usual doses Rare clinically apparent liver injury has been reported with oral Centella products; stop use and seek care if jaundice, dark urine, severe fatigue or right-upper-abdominal pain occurs
Pregnancy and breastfeeding Avoid concentrated supplements unless prescribed by a qualified practitioner or healthcare provider Avoid concentrated supplements unless prescribed by a qualified practitioner or healthcare provider

Dosage and Preparation: Do Not Transfer Doses Across Plants

A Bacopa dose should not be copied onto a Centella product, and a Centella triterpenic-fraction dose should not be copied onto a Bacopa product. The pharmacopoeial powder dose for Brahmi is 1–3 g, while the API dose for Mandukaparni is 5–10 g. Modern standardized extracts add another layer because the marker compounds and percentage standardizations differ.

  • Brahmi powder: API dose is 1–3 g of Bacopa monnieri powder.
  • Bacopa standardized extract: Adult trial and clinical-reference ranges commonly use 300–450 mg per day of extract standardized to bacosides or bacopa glycosides.
  • Mandukaparni dried drug: API dose is 5–10 g of Centella asiatica.
  • Centella triterpenic fraction: Venous microcirculation studies have used purified triterpenic fractions such as 60–120 mg daily under study conditions.

Traditional Formulations and Single-Herb Use

Brahmi and Mandukaparni appear in different practical formats. The API Brahmi monograph lists formulations such as Saraswatarishta, Brahmi Ghrita, Brahmi Vati, Sarasvata Churna and Smritisagara Rasa. For Mandukaparni, Charaka’s medhya rasayana passage specifically names Mandukaparni swarasa, or fresh juice, as the preparation in that context.

This distinction is useful at the prescription desk. If a clinician intends Brahmi Ghrita under the pharmacopoeial Brahmi identity, Bacopa monnieri is the expected plant. If the intended herb is Mandukaparni swarasa, the pharmacopoeial identity is Centella asiatica.

When Both Are Used Together

Some formulations and modern supplements use both Bacopa and Centella. That can be a deliberate choice, but it should be transparent. A combined product should state both botanical names and their respective quantities, rather than hiding the mixture under the single word “Brahmi.”

Using both herbs together does not remove the need for dose clarity. It increases the need for it, because each plant contributes its own constituents, actions and cautions.

Practical Recommendations for Consumers

The safest buying rule is simple: never rely on the name “Brahmi” alone. Look for the Latin botanical name, the part used, the extract ratio or standardization, the dose per serving, and quality-testing information.

  • For Bacopa: the label should say Bacopa monnieri and, for extracts, ideally specify bacosides or bacopa glycosides.
  • For Centella: the label should say Centella asiatica and, for extracts, ideally specify asiaticoside, madecassoside, total triterpenes or TTFCA-type standardization.
  • For fresh herbs: Bacopa has small opposite fleshy leaves and a wetland habit; Centella has kidney-shaped leaves on longer petioles and creeps by stolons.
  • For prescriptions: ask the practitioner whether the intended plant is Bacopa monnieri, Centella asiatica, or both.
  • For children, pregnancy, breastfeeding, chronic illness or prescription medicines: use only under qualified professional guidance.

The Clean Resolution

The most practical resolution is not to argue over which regional usage is “wrong,” but to standardize communication. In current pharmacopoeial usage, write and dispense Brahmi (Bacopa monnieri) when Bacopa is intended, and Mandukaparni (Centella asiatica) when Centella is intended.

Both herbs have legitimate Ayurvedic value. The problem begins only when one name is used without botanical clarity. Accurate naming protects classical integrity, clinical intent, product quality and patient safety.

Medical Disclaimer: This article is for educational purposes only and does not replace individualized advice. Consult a qualified Ayurvedic practitioner or healthcare provider before using Brahmi, Mandukaparni or any concentrated herbal supplement, especially if you are pregnant, breastfeeding, giving it to a child, taking prescription medicines, or living with thyroid, liver, neurological or cardiovascular conditions.

References

  1. Ayurvedic Pharmacopoeia of India
  2. Ayurvedic Pharmacopoeia of India
  3. Powo (powo.science.kew.org)
  4. Powo (powo.science.kew.org)
  5. Powo (powo.science.kew.org)
  6. Powo (powo.science.kew.org)
  7. Charaka Samhita — Rasayana Adhyaya
  8. Phytopharmajournal (phytopharmajournal.com)
  9. NCBI
  10. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract (2014), PubMed
  11. NCBI
  12. SAGE Journals
  13. A Systematic Review of the Efficacy of Centella asiatica for Improvement of the Signs and Symptoms of Chronic Venous Insufficiency (2013), PubMed Central
  14. Hepatotoxicity associated with the ingestion of Centella asiatica (2005), PubMed
  15. NCCIH
Tags: Ayurvedic Nomenclature Bacopa Brahmi Centella asiatica Herb Identity Mandukaparni Pharmacognosy